An Open-Label, Observational, Multicenter Study to Evaluate the Impact of AVONEX PEN Autoinjector Therapy on Work Capacity of Multiple Sclerosis Patients in Canada.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Acronyms CAPPS
- Sponsors Biogen Idec
- 18 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Dec 2011 New trial record